ArticleInteractive journal of medical research2025
Streamlining Ophthalmic Documentation With Anonymized, Fine-Tuned Language Models: Feasibility Study.
Article in Interactive journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe growing administrative burden on clinicians, particularly in medical documentation, contributes to burnout and may compromise patient safety. Recent advancements in generative artificial intelligence (AI) offer a promising solution to improve documentation processes and address these challenges.
objectiveThis study aims to evaluate the feasibility of using a fine-tuned OpenAI Curie model to automate the generation of medical report summaries (epicrises) in ophthalmology. By assessing the model's performance through human and automated evaluations, this study seeks to determine its potential for reducing clinician workload while ensuring accuracy, usefulness, and compliance with regulatory requirements.
methodsA data set of around 60,000 anonymized medical letters was created using a custom algorithm to comply with General Data Protection Regulation guidelines. The Curie model was fine-tuned on this data set to generate epicrises from medical histories, diagnoses, and findings. The performance evaluation involved various human assessments and automated evaluations from 2 large language models (LLMs).
resultsIn the clinical context, 49.9% (384/769) of epicrises were evaluated as helpful or excellent, whereas only 25% (194/769) were considered disturbing. In a human (manual) evaluation, formal correctness was rated significantly higher than the neutral midpoint of 2.5 on the 4-point rating scale, as determined by a 1-sample Wilcoxon signed-rank test (mean 3.59, SD 0.85; W=1686; P<.001). Using paired t tests, we found a significant reduction in time, as correcting an AI epicrisis was faster than manually writing one (mean 109.52, SD 53.30 vs mean 54.25, SD 63.34 s; t
conclusionsOur study demonstrates the technical and practical feasibility of introducing fine-tuned commercial LLMs into clinical practice. The AI-generated epicrises were formally and clinically correct in many cases and showed time-saving potential. While medical accuracy and usefulness varied across cases and should be focused on in further developments, a significant workload reduction is likely. Our anonymization process showed that regulatory challenges in the context of AI with patient data can effectively be dealt with. In summary, this study highlights the promise of transformer-based LLMs in reducing administrative tasks in health care. It outlines a pipeline for integrating LLMs into European Union clinical practice, emphasizing the need for careful implementation to ensure efficiency and patient safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.